Prof. Dr. Sang-We Kim
Cancer Treatment
31+
Years of Experience
FREE HOTEL & FLIGHTS
100% OFF ON DENTAL CHECKUP
BEST PRICE GUARANTEED
About Prof. Dr. Sang-We Kim
Prof. Sang-We Kim is a Medical Oncologist and Professor in the Department of Oncology at Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. He is one of the top thoracic oncologists in Korea, with a particular special interest in advanced non-small cell lung cancer (NSCLC) and targeted therapy.
Professional Background
- Based in: Seoul, South Korea
- Affiliation: Department of Oncology, Asan Medical Center
- Citations: 2,875+ across 26+ research works
Innovations & Contributions
Prof. Kim is a global leader in the research of EGFR/ALK targeted therapy and lung cancer clinical trials.
- DESTINY-Lung02 Trial: Co-investigator of the pivotal phase 2 trial of trastuzumab deruxtecan (T-DXd) in NSCLC with HER2 mutations published in Journal of Thoracic Oncology (2025).
- EGFR & ALK TKI Research: Principal investigator for several studies assessing nazartinib, gefitinib and ALK inhibitors as treatments for advanced non-small cell lung cancer (NSCLC) positive for EGFR/ALK; publications in BMC Cancer and international oncology journals.
- CheckMate Trials: Co-author on pooled safety analysis of nivolumab plus ipilimumab across CheckMate 227, 568, and further lung cancer immunotherapy studies.
Good to know
Speciality
Language Spoken
Awards
- • International Association for the Study of Lung Cancer
- • Korean Society of Medical Oncology
Senior Professor
Medical Oncologist
Performed by Prof. Dr. Sang-We Kim
Cancer Treatment
Cancer treatment abroad gives patients an access to world-class oncology centers offering chemotherapy, immunotherapy, targeted therapy, radiation, and surgical oncology. Multidisciplinary tumor boards of oncologists, surgeons, and radiologists collaborate to design personalized treatment plans. Oncology care costs can be financially devastating in many countries. Advanced cancer treatments that cost $80,000 to $200,000 at home may be available for $15,000 to $50,000 abroad at JCI-accredited hospitals with equally qualified oncologists and the latest treatment technologies. International cancer centers provide comprehensive care including PET-CT imaging, genomic tumor profiling, and access to clinical trials not available locally. Dedicated oncology case managers guide patients through every step of their treatment journey. The oncologist's experience and the hospital's technology are the most important factors to consider to ensure authenticity. Always confirm your treating team includes board-certified oncologists and that the facility is accredited by a recognized international body. Adherence to your full treatment protocol, nutritional support, and psychological well-being during treatment all significantly influence outcomes.
CureMeAbroadIs Absolutely Free
Just discovery so you can choose what's right for you!
World's No. 1 Medical Discovery Platform
Prof. Dr. Sang-We Kim
Sang-We Kim has been practicing medicine since 1995, giving them over 30 years of clinical experience. They currently serve as Professor of Medical Oncology and have built a focused career in medical oncologist.
Prof. Dr. Sang-We Kim
You can request a consultation with Sang-We Kim through CureMeAbroad by submitting your details. Video consultations are available for international patients before travel through CureMeAbroad.
Prof. Dr. Sang-We Kim
Cancer treatment costs with Sang-We Kim vary by cancer type, stage, and treatment protocol. Patients frequently save 40-70% compared to equivalent care in the US or UK. CureMeAbroad can help obtain a cost estimate after your medical records and pathology reports are reviewed.
How many years of experience does Sang-We Kim have?
Prof. Dr. Sang-We Kim
Sang-We Kim has been practicing medicine since 1995, giving them over 30 years of clinical experience. They currently serve as Professor of Medical Oncology and have built a focused career in medical oncologist.
Which You Wanted To See
Topic Related
